IGF1 and Alzheimer disease: Another intriguing pathway identified was the regulation of insulin-like growth factor (IGF) transport and uptake, aligning with the long-standing hypothesis that the STZ-icv model mimics human sAD by disrupting brain insulin signaling—a central feature of molecular pathways implicated in AD (Alves et al. 2021).